2021-05-07T15:09:28-05:00 2020-06-30 GRANT THORNTON LLP 75 State Street Boston MA 02109 990 2019-07-01 042104230 Forsyth Dental Infirmary for Children % WANDA CORDOVA FORS 6172625200 245 First Street Cambridge MA 02142 WANDA CORDOVA CFO 6172625200 2021-05-07 true Erin Couture P01390592 6177237900 2019 2022-09-23 18:48:47Z The Forsyth Institute Wenyuan Shi CEO 245 First Street Cambridge MA 02142 15245247 false X www.forsyth.org X 1910 MA TO IMPROVE ORAL AND OVERALL HEALTH THROUGH COMBINATION OF INNOVATIVE RESEARCH AND COMMUNITY OUTREACH BY ACCELERATING THE DELIVERY OF WELLNESS SOLUTIONS LOCALLY AND GLOBALLY. 21 20 161 107 665592 -795909 13809241 10237601 4096235 3594578 2082457 1298511 1032193 31546 21020126 15162236 1620446 1156844 0 0 12488907 12452850 0 0 244127 11917454 10972924 26026807 24582618 -5006681 -9420382 52655810 46427599 6277101 9531864 46378709 36895735 X FOR MORE THAN 100 YEARS, FORSYTH HAS BEEN A LEADER IN THE FIELDS OF DENTAL RESEARCH AND PEDIATRIC DENTAL CARE. TODAY, WE ARE GROUNDED IN A 3-PILLARED STRATEGIC PLAN FOCUSED ON (SCHEDULE O) false false 17753164 1156844 3594578 THE FORSYTH INSTITUTE IS THE ONLY INDEPENDENT RESEARCH INSTITUTE IN THE UNITED STATES FOCUSING ON THE CONNECTIONS BETWEEN ORAL HEALTH AND OVERALL WELLNESS. 17753164 true true false true false false false false false true true true false false true true false true false false true true false false true false false true false true false false false false false false false false false false false false true true true true false false true 38 0 true 161 true true true false false false false false false false false false false false X 21 20 false false false false false false false true true false false true true true true true true true true true true MA X X WANDA CORDOVA 6178928367 245 FIRST STREET Cambridge MA 02142 DR WENYUAN SHI CEO & Chief Scientific Officer 45.0 0.0 X X 412670 0 34126 DR THOMAS E VAN DYKE VP CLINICAL & TRANS. RES. 45.0 0.0 X 309003 0 26380 DR FLOYD DEWHIRST Senior Scientist 45.0 0.0 X 220702 0 48977 DR PRAMOD M SOPARKAR Senior Scientist 45.0 0.0 X 220239 0 37260 MS WANDA CORDOVA CFO & TREASURER 45.0 0.0 X 225455 0 20939 DR IBRAHIM KANTARCI Associate Scientist 45.0 0.0 X 195830 0 26666 MS PAULA LAPALME CHIEF ADMINISTRATION OFFICER 45.0 0.0 X 183264 0 25313 DR XUESONG HE Associate Scientist 45.0 0.0 X 181486 0 16141 MS GENEVIEVE HOLMESTHRU 320 chief project officer & Sec 45.0 0.0 X 111457 0 10014 MSCARLINE DUROCHERAS of 320 GENERAL LEGAL COUNSEL & SEC 45.0 0.0 X 75838 0 15950 MS ELYSE D CHERRY director/chair (as of 03/2020) 4.0 0.0 X X 0 0 0 MR PETER NESSEN Chair (thru 03/2020)/Director 4.0 0.0 X X 0 0 0 DR DAVID W ELLIS Vice Chair 1.0 0.0 X X 0 0 0 MR RICHARD ANDERS Director 1.0 0.0 X 0 0 0 MS JANICE BOURQUE Director 1.0 0.0 X 0 0 0 MS PAMELA CARRINGTON SCOTT Director 1.0 0.0 X 0 0 0 MS PAMELA N CZEKANSKI Director (AS OF 10/2019) 1.0 0.0 X 0 0 0 MS CATHERINE D'AMATO Director 1.0 0.0 X 0 0 0 DR BRUCE DONOFF Director 1.0 0.0 X 0 0 0 MR DAI FENG Director 1.0 0.0 X 0 0 0 DR JOHN FICARELLI Director (THRU 10/2019) 1.0 0.0 X 0 0 0 MR MICHAEL GREELEY Director 1.0 0.0 X 0 0 0 MS ROSALEE HERMENS Director 1.0 0.0 X 0 0 0 MS KARLA L JARVIS Director 1.0 0.0 X 0 0 0 MS JANET KELLY Director 1.0 0.0 X 0 0 0 MR RAJI KOHLI DIRECTOR 1.0 0.0 X 0 0 0 DR BRUCE LIEBERTHAL Director (AS OF 06/2020) 1.0 0.0 X 0 0 0 MR MICHAEL MONOPOLI Director 1.0 0.0 X 0 0 0 MR JOHN M PLUKAS Director 1.0 0.0 X 0 0 0 MR WALTER M PRESSEY Director 1.0 0.0 X 0 0 0 MS ROBYN REDFIELD Director 1.0 0.0 X 0 0 0 2135944 0 261766 27 false true false Foley Hoag LLP 155 Seaport Boulevard BOSTON MA 02210 Legal 347158 Aqueduct Technologies Inc 333 Wyman Street Suite 300 WALTHAM MA 02451 IT Managed Services 297734 Taconic Alliance LLC 71 Revere Street BOSTON MA 02114 Consulting Services 113075 3 16217 8609994 1611390 10237601 RESEARCH 541700 1007180 1007180 0 0 DENTAL SERVICES 621400 858605 193013 665592 0 FESC RESEARCH CENTER 541700 1728793 1728793 0 0 3594578 634383 634383 0 0 0 0 0 632228 31900 632228 31900 664128 664128 40000 16217 83011 -43011 -43011 0 0 0 0 0 0 MISCELLANEOUS INCOME 900099 74557 0 0 74557 74557 15162236 2928986 665592 1330057 1062895 1062895 0 93949 93949 0 1361513 264024 1007000 90489 0 8260678 5874074 2352697 33907 676733 470222 196458 10053 1516524 929712 568046 18766 637402 406847 222180 8375 0 224529 3336 219863 1330 80359 80359 68805 66142 2663 0 171740 171740 765264 337231 428033 66310 4810 61500 0 318930 17983 291550 9397 0 4807942 4520795 261043 26104 175713 97033 49425 29255 0 67527 25646 39857 2024 3077 3077 0 2477466 2419335 52846 5285 204434 26426 178008 SUPPLIES 853484 763640 85940 3904 LOSS ON ASSETS 18375 18375 0 0 OTHER EXPENSES 668969 350689 313042 5238 24582618 17753164 6585327 244127 537481 1234332 305000 300000 0 0 2400428 3064974 0 0 0 0 0 0 0 0 281060 224790 29912943 22528046 9470454 7384897 34788407 29959133 4872980 4259473 0 0 0 0 0 0 52655810 46427599 1834699 1915539 0 0 292203 441053 0 0 0 0 0 0 0 0 0 2814900 4150199 4360372 6277101 9531864 X 46371208 36853234 7501 42501 46378709 36895735 52655810 46427599 -9420382 -62592 X false true X true true true X 15255665 16616306 11497146 13809241 10237652 67416010 6921017 2190176 2920350 3366338 2928986 18326867 0 0 0 22176682 18806482 14417496 17175579 13166638 85742877 57075 37585 32050 10500 41500 178710 746234 1558289 1536558 1929134 5770215 57075 783819 1590339 1547058 1970634 5948925 79793952 996363 661633 1063100 2052920 634383 5408399 0 996363 661633 1063100 2052920 634383 5408399 0 173513 184461 493402 302674 114557 1268607 23346558 19652576 15973998 19531173 13915578 92419883 0.86338 0.89004 0.05852 0.05762 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 68805 68805 24342073 24410878 1000000 250000 false 1000000 1000000 1000000 1000000 4000000 6000000 12060 68133 68496 68805 217494 250000 250000 250000 250000 1000000 1500000 LOBBYING ACTIVITY EXPENSES INCLUDE A CONTRACT WITH A LOBBYING FIRM FOR ASSISTANCE WITH STATE GRANT LOBBYING. ADDITIONALLY, FORSYTH BELONGS TO MEMBERSHIP ORGANIZATIONS WHICH ENGAGE IN LOBBYING ACTIVITIES. A PORTION OF THE DUES PAID ARE SPECIFICALLY IDENTIFIED AS LOBBYING EXPENSES. 39661387 1032607 6475388 34218606 44278955 2371539 1341452 8330559 39661387 49276967 4245291 9243303 44278955 50258923 5209122 6191078 49276967 58466801 -1362958 6844920 50258923 1.00000 false true 0 16774746 10708328 6066418 0 11417547 10487350 930197 0 1720650 1332368 388282 7384897 PRIVATE EQUITY INVESTMENTS 4259473 F 4259473 0 DEFERRED RENT 4360372 4360372 X 14927904 -62592 -62592 14990496 171740 171740 15162236 24410878 24410878 171740 171740 24582618 INTENDED USES OF ENDOWMENT FUNDS SCHEDULE D, PART V, LINE 4 TO SUPPORT THE CHARITABLE MISSION OF THE FORSYTH DENTAL INFIRMARY FOR CHILDREN. ASC 740 FOOTNOTE SCHEDULE D, PART X, LINE 2 THE INSTITUTE (AND FORSYTH INTERNATIONAL) ARE ORGANIZATIONS DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, AS AMENDED (THE "CODE"), AND ARE GENERALLY EXEMPT FROM INCOME TAXES PURSUANT TO SECTION 501(A) OF THE CODE. THE INSTITUTE TO IDENTIFY UNCERTAIN TAX POSITIONS AND HAS DETERMINED THAT NO SUCH POSITIONS EXIST THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. true Europe (Including Iceland and Greenland) 0 0 Grantmaking Research 93949 0 0 0 0 93949 93949 Europe (Including Iceland and Greenland) PROGRAM SUPPORT 93949 CHECK 1 0 false false false false false true SCHEDULE F, PART I, LINE 2 THE INSTITUTE ASSIGNS RESPONSIBILITY FOR MONITORING THE USE OF GRANT FUNDS OUTSIDE OF THE UNITED STATES TO ITS OFFICE OF SPONSORED RESEARCH. THIS OFFICE MONITORS ALL GRANT MAKING ACTIVITY INCLUDING ALL APPLICABLE COMPLIANCE REGULATIONS. MONITORING INCLUDES PERIODIC REVIEWS OF BUDGET TO ACTUAL REPORTS BY BOTH THE OFFICE OF SPONSORED RESEARCH AND THE PRINCIPAL INVESTIGATOR TO ENSURE FUNDS ARE USED ACCORDING TO THE AGREEMENT. EXPENSES ARE ACCOUNTED FOR ON AN ACCRUAL BASIS. SCHEDULE F, PART I, LINE 3, COLUMN(F) THE INSTITUTE USES THE ACCRUAL METHOD OF ACCOUNTING. MA Taste & Toast 56217 16217 40000 83011 1 56217 16217 40000 83011 83011 -43011 true Boston University 85 East Newton St M-921 Boston MA 02118 042103547 501(c)(3) 22805 Program Support Brigham & Women's Hospital 77 Louis Paster Ave Boston MA 02115 042312909 501(c)(3) 83941 Program Support Marine Biological Laboratory 7 Mbl St Woods Hole MA 02543 042104690 501(c)(3) 149262 Program Support Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(c)(3) 29167 Program Support Northwestern University 633 Clark Street Evanston IL 60208 362167817 501(c)(3) 59708 Program Support President & Fellows of Harvard College 677 Huntington Avenue Boston MA 02115 042103580 501(c)(3) 70378 Program Support Stanford University 3160 Porter Drive Palo Alto CA 94304 941156365 501(c)(3) 10423 Program Support The Jackson Laboratory 610 Main Street Bar Harbor ME 04609 010211513 501(c)(3) 30601 Program Support Tufts Medical Center 136 Harrison Ave Boston MA 02111 042103634 501(c)(3) 144874 Program Support University of Washington 4333 Brooklyn Avenue NE Seattle WA 98195 916001537 Gov't 408536 Program Support Vanderbilt University 23rd Ave S at Pierce Nashville TN 37232 620476822 501(c)(3) 8879 Program Support Yale University 25 Science Park3rd Flr New Haven CT 06508 060646973 501(c)(3) 39140 Program Support 12 ORGANIZATION'S PROCEDURES FOR MONITORING THE USE OF GRANTS IN THE U.S. SCHEDULE I, PART I, LINE 2 THE INSTITUTE ASSIGNS RESPONSIBILITY FOR MONITORING THE USE OF GRANT FUNDS TO ITS OFFICE OF SPONSORED RESEARCH. THIS OFFICE MONITORS ALL GRANT MAKING ACTIVITY INCLUDING ALL APPLICABLE COMPLIANCE REGULATIONS. MONITORING INCLUDES PERIODIC REVIEWS OF BUDGET TO ACTUAL REPORTS BY BOTH THE OFFICE OF SPONSORED RESEARCH AND THE PRINCIPAL INVESTIGATOR TO ENSURE FUNDS ARE USED ACCORDING TO THE AGREEMENT. EXPENSES ARE ACCOUNTED FOR ON AN ACCRUAL BASIS. X X X X false false false false false false false false false DR WENYUAN SHI CEO & Chief Scientific Officer 409316 0 0 0 3354 0 25200 0 8926 0 446796 0 0 0 MS WANDA CORDOVA CFO & TREASURER 223956 0 0 0 1499 0 20939 0 0 0 246394 0 0 0 DR THOMAS E VAN DYKE VP CLINICAL & TRANS. RES. 302691 0 0 0 6312 0 25200 0 1180 0 335383 0 0 0 DR FLOYD DEWHIRST Senior Scientist 215045 0 0 0 5657 0 20309 0 28668 0 269679 0 0 0 DR PRAMOD M SOPARKAR Senior Scientist 210648 0 0 0 9591 0 19669 0 17591 0 257499 0 0 0 DR IBRAHIM KANTARCI Associate Scientist 194754 0 0 0 1076 0 17740 0 8926 0 222496 0 0 0 MS PAULA LAPALME CHIEF ADMINISTRATION OFFICER 177693 0 0 0 5571 0 16387 0 8926 0 208577 0 0 0 DR XUESONG HE Associate Scientist 180722 0 0 0 764 0 16141 0 0 0 197627 0 0 0 MISSION STATEMENT (CONTINUED) FORM 990, PART III, LINE 1 BIOLOGICAL RESEARCH, CLINICAL SERVICE AND PUBLIC HEALTH OUTREACH, AND TECHNOLOGICAL INNOVATION. PILLAR 1: FORSYTH HAS A LONG LEGACY OF CHANGING THE ORAL HEALTH LANDSCAPE THROUGH DENTAL RESEARCH, DENTAL CLINICAL TRIALS, AND TRAINING. FOR DECADES, FORSYTH HAS BEEN A TOP-TIER INSTITUTION IN NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH FUNDING. OUR SCIENTISTS HAVE CONTRIBUTED TO THE HIGHEST IMPACT PUBLICATIONS IN THE ORAL HEALTH FIELD. PILLAR 2: THE FORSYTH INSTITUTE IS COMMITTED TO IMPROVING PUBLIC HEALTH IN THE COMMUNITIES WE SERVE. SINCE ITS INCEPTION IN 1910 AS A DENTAL INFIRMARY FOR CHILDREN, FORSYTH HAS ESTABLISHED ITSELF AS A PIONEER IN PEDIATRIC DENTISTRY, TREATING HUNDREDS OF THOUSANDS OF CHILDREN IN NEED ACROSS MASSACHUSETTS. FORSYTH CONTINUES TO CARRY OUT OUR FOUNDING MISSION PROVIDING ORAL HEALTH CARE THROUGH MOBILE, PRIVATE PRACTICE, AND GLOBAL PROGRAMS. IN 2001, FORSYTHKIDS BEGAN USING VANS TO DELIVER PREVENTIVE DENTAL CARE TO CHILDREN OF ALL AGES AT SCHOOLS, DAYCARES, SUMMER CAMPS, AND COMMUNITY CENTERS ACROSS MASSACHUSETTS. THE PROGRAM HAS PROVIDED CARE TO TENS OF THOUSANDS OF CHILDREN SINCE ITS INCEPTION. PILLAR 3: THE FORSYTH INSTITUTE IS UNIQUELY SUITED TO LEAD THE DEVELOPMENT OF NOVEL ORAL HEALTH TECHNOLOGIES. OUR ENTREPRENEURIAL SPIRIT ENCOURAGES RESEARCHERS TO BRING THEIR EXPERTISE TO THE COMMERCIAL MARKETPLACE, AND OUR CLINICAL TEAM IS EXPERIENCED IN PARTNERING WITH INDUSTRY TO TEST NEW TREATMENTS AND PRODUCTS. FORSYTHS CENTER FOR CLINICAL AND TRANSLATIONAL RESEARCH OFFERS A HIGHLY SKILLED AND EXPERIENCED TEAM OF ADMINISTRATIVE STAFF, DENTAL PROFESSIONALS, LABORATORY TECHNICIANS, AND SUBJECT RECRUITMENT SPECIALISTS TO MEET EVERY NEED OF A RESEARCH PROJECT OR CLINICAL TRIAL. AS AN INDEPENDENT RESEARCH INSTITUTE, FORSYTH HAS THE FREEDOM TO FOLLOW OUR SCIENCE WHEREVER IT LEADS AND TO COLLABORATE WITH A BROAD SPECTRUM OF STAKEHOLDERS. THE INSTITUTE IS LOCATED IN KENDALL SQUARE, CAMBRIDGE, AN EPICENTER OF BIOTECHNOLOGY WITH ONE OF THE HIGHEST DENSITIES OF BIOMEDICAL RESEARCHERS IN THE WORLD. FORM 990 REVIEW PROCESS FORM 990, PART VI, SECTION B, LINE 11B THE RETURN WAS PREPARED BY TAX ADVISORS FROM A NATIONAL ACCOUNTING FIRM WITH INFORMATION PROVIDED BY MANAGEMENT. THE DRAFT FORM 990 IS REVIEWED BY THE CEO, CFO, AND THE AUDIT, RISK & COMPLIANCE COMMITTEE OF THE BOARD OF DIRECTORS. IT IS THEN DISTRIBUTED TO EACH MEMBER OF THE BOARD OF DIRECTORS BEFORE FILING. CONFLICT OF INTEREST POLICY MONITORING & ENFORCEMENT FORM 990, PART VI, SECTION B, LINE 12C FORSYTH'S CONFLICT OF INTEREST POLICY APPLIES TO FORSYTH'S BOARD MEMBERS, OFFICERS, ADMINISTRATORS, AND RESEARCH EMPLOYEES AND WAS ESTABLISHED TO PROTECT THE INTEREST OF THE INSTITUTE - THE DESIGN, CONDUCT, OR REPORTING OF OPERATIONS OR RESEARCH. CONSISTENT WITH THE POLICY, OFFICERS, ADMINISTRATORS, RESEARCH STAFF EMPLOYEES AND BOARD MEMBERS ARE REQUIRED TO COMPLETE AN ANNUAL CONFLICT OF INTEREST DISCLOSURE FORM. TO ACCOMPLISH THIS OBJECTIVE, THIS POLICY ESTABLISHES A DISCLOSURE SYSTEM WHEREBY POTENTIAL CONFLICT SITUATIONS WILL BE IDENTIFIED, REVIEWED AND ADDRESSED. FORSYTH OFFICERS, ADMINISTRATORS, AND RESEARCH EMPLOYEES - FORSYTH'S GENERAL COUNSEL IS THE INSTITUTIONAL OFFICIAL WHO IS RESPONSIBLE FOR DISSEMINATING THE CONFLICT OF INTEREST POLICY AND COLLECTING SIGNED DISCLOSURE STATEMENTS WHEN THE EMPLOYEES ARE FIRST HIRED AND ANNUALLY THEREAFTER. THE RESOLUTION OF ANY CONFLICT OR PERCEIVED CONFLICT IS IDENTIFIED BY THE INSTITUTIONAL OFFICIAL, IN CONSULTATION WITH FORSYTH'S CONFLICT OF INTEREST COMMITTEE. FORSYTH BOARD MEMBERS - THE SECRETARY OF THE BOARD IS RESPONSIBLE FOR DISSEMINATING THE CONFLICT OF INTEREST POLICY AND COLLECTING SIGNED DISCLOSURE STATEMENTS FROM BOARD MEMBERS AT THE TIME THEY ARE APPOINTED AND ANNUALLY THEREAFTER. THE RESOLUTION OF ANY CONFLICT OR PERCEIVED CONFLICT IS IDENTIFIED BY THE SECRETARY IN CONSULTATION WITH THE CHAIRMAN OF FORSYTH'S BOARD OF DIRECTORS. AS A VOTING BOARD MEMBER, THE CEO DOES NOT VOTE ON AND IS RECUSED WHEN A CONFLICT OF INTEREST ARISES. PROCESS FOR DETERMINING COMPENSATION FORM 990, PART VI, SECTION B, LINES 15A AND 15B CEO COMPENSATION IS REVIEWED AND APPROVED ANNUALLY BY THE EXECUTIVE COMMITTEE OF THE INDEPENDENT BOARD OF DIRECTORS. COMPARABLE COMPENSATION DATA AND FORM 990 DATA FROM OTHER ORGANIZATIONS ARE UTILIZED FOR THE REVIEW OF CEO COMPENSATION. THE CEO REVIEWS AND APPROVES COMPENSATION FOR THE EXECUTIVE MANAGEMENT, USING MARKET SURVEYS AND FORM 990 DATA FOR OTHER SIMILAR ORGANIZATIONS. THESE DECISIONS ARE REVIEWED BY THE BOARD OF DIRECTORS. ANNUALLY, FORSYTH PARTICIPATES IN A COMPENSATION SURVEY THAT INCLUDES COMPARATIVE DATA OF SIMILAR ORGANIZATIONS. THESE ANALYSES ARE UTILIZED IN THE REVIEW OF THE CEO AND EXECUTIVE MANAGEMENT'S COMPENSATION. BOTH THE DELIBERATION AND DECISION PROCESS FOR DETERMINING COMPENSATION OF THE CEO AND EXECUTIVE MANAGEMENT IS CONTEMPORANEOUSLY DOCUMENTED. HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC FORM 990, PART VI, LINE 19 THE FORSYTH INSTITUTE MAKES ITS GOVERNING DOCUMENTS, WRITTEN POLICIES AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. THESE ITEMS ARE AVAILABLE UPON REQUEST. Forsyth Innovation LLC 245 First Street Cambridge MA 02142 Tech Dev DE 0 0 Forsyth Forsyth International Inc 245 FIRST STREET CAMBRIDGE MA 02142 043443294 DENTAL CARE MA 501(C)(3) 09 FORSYTH true Beneficial Interest in Trust Trust MA Forsyth Trust 0 0 1.00000 true false false false false false false false false false false false false false false false false false false false